Towards a Novel Class of Multitarget-Directed Ligands: Dual P2X7–NMDA Receptor Antagonists
Open Access
Abstract
Multi-target-directed ligands (MTDLs) offer new hope for the treatment of multifactorial complex diseases such as Alzheimer’s Disease (AD). Herein, we present compounds aimed at targeting the NMDA and the P2X7 receptors, which embody a different approach to AD therapy. On one hand, we are seeking to delay neurodegeneration targeting the glutamatergic NMDA receptors; on the other hand, we also aim to reduce neuroinflammation, targeting P2X7 receptors. Although the NMDA receptor is a widely recognized therapeutic target in treating AD, the P2X7 receptor remains largely unexplored for this purpose; therefore, the dual inhibitor presented herein—which is open to further optimization—represents the first member of a new class of MTDLs.Keywords
Funding Information
- Ministerio de Economía y Competitividad (SAF2014-57094-R)
- GIST Research Institute
- European Regional Development Fund
This publication has 49 references indexed in Scilit:
- Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s DiseaseNeurotoxicity Research, 2013
- The P2X7 receptor as a route for non‐exocytotic glutamate release: dependence on the carboxyl tailJournal of Neurochemistry, 2013
- Alzheimer's disease, β‐amyloid, glutamate, NMDA receptors and memantine – searching for the connectionsBritish Journal of Pharmacology, 2012
- Structure–Activity Relationships and Optimization of 3,5-Dichloropyridine Derivatives As Novel P2X7 Receptor AntagonistsJournal of Medicinal Chemistry, 2012
- Neurotoxicity of Amyloid -Protein: Synaptic and Network DysfunctionCold Spring Harbor Perspectives in Medicine, 2012
- The Purinergic Receptor P2X7 Triggers α-Secretase-dependent Processing of the Amyloid Precursor ProteinJournal of Biological Chemistry, 2011
- Differential Roles of NMDA Receptor Subtypes NR2A and NR2B in Dendritic Branch Development and Requirement of RasGRF1Journal of Neurophysiology, 2010
- P2X7, NMDA and BDNF receptors converge on GSK3 phosphorylation and cooperate to promote survival in cerebellar granule neuronsCellular and Molecular Life Sciences, 2010
- A Century of Alzheimer's DiseaseScience, 2006
- β-Amyloid25-35 inhibits glutamate uptake in cultured neurons and astrocytes: modulation of uptake as a survival mechanismNeurobiology of Disease, 2004